On 8th October 2020, Glycostem participates 2020 ISPE Biotechnology Virtual Conference. Glycostem CDO Volker Huppert presents our GMP manufacturing method of an off-the-shelf cell therapy product.
Glycostem participates the CBIIC (China BioMed Innovation and Investment Conference) virtual roadshow on 21st Sep 2020. Our CEO Troels Jordansen talks about the our company, pipelines and the forward-looking prospects of Glycostem.
Glycostem presents virtually at Innate Killer Summit 2020 our production system for off-the-Shelf, GMP Compliant, fully closed & semi-automated large-scale (oNKord®) from fresh umbilical cord blood stem cells.
Glycostem is honored being seleced to be part of SVB Leerink Biopharma Private Company Connect on 7th to 9th July. It is a series of 1:1 between investors and Glycostem, one of the last formally organized investor conferences before the European summer break.
Glycostem CEO Troels Jordansen presents on 25th June at the upcoming Virtual European Biotech Investor Day 2020 hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq.
Glycostem is invited to the second largest investor conference: the Jefferies Virtual Healthcare Conference on 4th July. The interest in off-the-shelf NK-cells with no CRS issues is increasing rapidly.